Editorial: Therapeutics in pulmonary arterial hypertension.
作者信息
Adão Rui, Perez-Vizcaino Francisco, Redwan Bassam, Brás-Silva Carmen
机构信息
Cardiovascular R&D Centre-UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Porto, Portugal.
Department of Pharmacology and Toxicology, School of Medicine, University Complutense of Madrid, Madrid, Spain.
出版信息
Front Cardiovasc Med. 2024 Aug 6;11:1463305. doi: 10.3389/fcvm.2024.1463305. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Therapeutics in pulmonary arterial hypertension.社论：肺动脉高压的治疗方法
Front Cardiovasc Med. 2024 Aug 6;11:1463305. doi: 10.3389/fcvm.2024.1463305. eCollection 2024.
2
Hot topics in the mechanisms of pulmonary arterial hypertension disease: cancer-like pathobiology, the role of the adventitia, systemic involvement, and right ventricular failure.肺动脉高压疾病机制的热点话题：类癌病理生物学、外膜的作用、全身受累及右心室衰竭。
Pulm Circ. 2019 Nov 20;9(4):2045894019889775. doi: 10.1177/2045894019889775. eCollection 2019 Oct-Dec.
3
Pulmonary vascular mechanical consequences of ischemic heart failure and implications for right ventricular function.缺血性心力衰竭的肺血管机械性后果及其对右心室功能的影响。
Am J Physiol Heart Circ Physiol. 2019 May 1;316(5):H1167-H1177. doi: 10.1152/ajpheart.00319.2018. Epub 2019 Feb 15.
4
Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction.全球肺动脉高压与心力衰竭及射血分数保留或降低相关的血管重构。
Circulation. 2018 Apr 24;137(17):1796-1810. doi: 10.1161/CIRCULATIONAHA.117.031608. Epub 2017 Dec 15.
5
Is cardiac resynchronization therapy for right ventricular failure in pulmonary arterial hypertension of benefit?心脏再同步治疗对肺动脉高压所致右心室衰竭有益吗？
Pulm Circ. 2014 Dec;4(4):552-9. doi: 10.1086/678470.
6
Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.mTOR激酶的药理学抑制可逆转大鼠右心室重塑并改善右心室结构和功能。
Am J Respir Cell Mol Biol. 2017 Nov;57(5):615-625. doi: 10.1165/rcmb.2016-0364OC.
7
Role of Long Non-Coding RNAs in Pulmonary Arterial Hypertension.长链非编码 RNA 在肺动脉高压中的作用。
Cells. 2021 Jul 26;10(8):1892. doi: 10.3390/cells10081892.
8
Excitation-contraction coupling and relaxation alteration in right ventricular remodelling caused by pulmonary arterial hypertension.肺动脉高压导致右心室重构中的兴奋-收缩偶联和舒张改变。
Arch Cardiovasc Dis. 2020 Jan;113(1):70-84. doi: 10.1016/j.acvd.2019.10.009. Epub 2020 Jan 8.
9
Epigenetic Regulation of Pulmonary Arterial Hypertension-Induced Vascular and Right Ventricular Remodeling: New Opportunities?肺动脉高压诱导的血管和右心室重构的表观遗传调控：新的机会？
Int J Mol Sci. 2020 Nov 24;21(23):8901. doi: 10.3390/ijms21238901.
10
Evaluation of right coronary vascular dysfunction in severe pulmonary hypertensive rats using synchrotron radiation microangiography.应用同步辐射微血管成像技术评价严重肺动脉高压大鼠的右冠状动脉血管功能障碍。
Am J Physiol Heart Circ Physiol. 2021 Mar 1;320(3):H1021-H1036. doi: 10.1152/ajpheart.00327.2020. Epub 2021 Jan 22.
引用本文的文献
1
Gastric Epithelial Neoplasms in Patients with Pulmonary Arterial Hypertension Receiving Continuous Intravenous Prostacyclin Therapy.接受持续静脉注射前列环素治疗的肺动脉高压患者的胃上皮肿瘤
J Clin Med. 2025 Jan 25;14(3):791. doi: 10.3390/jcm14030791.
本文引用的文献
1
Mineralocorticoid Receptors in Vascular Smooth Muscle: Blood Pressure and Beyond.血管平滑肌中的盐皮质激素受体：血压与超越血压。
Hypertension. 2024 May;81(5):1008-1020. doi: 10.1161/HYPERTENSIONAHA.123.21358. Epub 2024 Mar 1.
2
Evaluation of , a novel thromboxane receptor antagonist, in a first-in-human phase I clinical trial.新型血栓素受体拮抗剂在首次人体I期临床试验中的评估。 （注：原文中“Evaluation of ”后面似乎缺少具体内容）
Front Pharmacol. 2023 Dec 21;14:1296188. doi: 10.3389/fphar.2023.1296188. eCollection 2023.
3
Therapeutic Approaches in Pulmonary Arterial Hypertension with Beneficial Effects on Right Ventricular Function-Preclinical Studies.肺动脉高压治疗方法对右心室功能有益的影响-临床前研究。
Int J Mol Sci. 2023 Oct 24;24(21):15539. doi: 10.3390/ijms242115539.
4
Novel Loss-of-Function Variants in Pulmonary Arterial Hypertension.肺动脉高压中的新型功能丧失变异。
Am J Respir Cell Mol Biol. 2023 Aug;69(2):147-158. doi: 10.1165/rcmb.2022-0245OC.
5
Risk stratification in adult and pediatric pulmonary arterial hypertension: A systematic review.成人及儿童肺动脉高压的风险分层：一项系统综述。
Front Cardiovasc Med. 2022 Nov 10;9:1035453. doi: 10.3389/fcvm.2022.1035453. eCollection 2022.
6
The association between self-reported mobile phone usage with blood pressure and heart rate: evidence from a cross-sectional study.自报的手机使用情况与血压和心率的关联：来自一项横断面研究的证据。
BMC Public Health. 2022 Nov 7;22(1):2031. doi: 10.1186/s12889-022-14458-1.
7
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Respir J. 2023 Jan 6;61(1). doi: 10.1183/13993003.00879-2022. Print 2023 Jan.
8
Vascular Endothelial Cells: Heterogeneity and Targeting Approaches.血管内皮细胞：异质性与靶向策略。
Cells. 2021 Oct 10;10(10):2712. doi: 10.3390/cells10102712.
9
Efficacy of the thromboxane receptor antagonist NTP42 alone, or in combination with sildenafil, in the sugen/hypoxia-induced model of pulmonary arterial hypertension.单独使用血栓素受体拮抗剂 NTP42 或与西地那非联合使用在 SuGEN/低氧诱导的肺动脉高压模型中的疗效。
Eur J Pharmacol. 2020 Dec 15;889:173658. doi: 10.1016/j.ejphar.2020.173658. Epub 2020 Oct 27.
10
Pulmonary arterial hypertension: Basic knowledge for clinicians.肺动脉高压：临床医生的基础知识。
Arch Cardiovasc Dis. 2016 Oct;109(10):550-561. doi: 10.1016/j.acvd.2016.03.004. Epub 2016 Aug 29.
Zotero 插件